1. Home
  2. SNFCA vs AKBA Comparison

SNFCA vs AKBA Comparison

Compare SNFCA & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Security National Financial Corporation

SNFCA

Security National Financial Corporation

N/A

Current Price

$8.79

Market Cap

229.2M

Sector

Finance

ML Signal

N/A

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

N/A

Current Price

$0.87

Market Cap

248.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SNFCA
AKBA
Founded
1965
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
229.2M
248.3M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
SNFCA
AKBA
Price
$8.79
$0.87
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $3.92
AVG Volume (30 Days)
21.4K
★ 5.8M
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
N/A
EPS Growth
13.51
★ 93.94
EPS
★ 0.60
N/A
Revenue
★ $344,587,538.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$14.67
★ N/A
Revenue Growth
★ 3.01
N/A
52 Week Low
$7.70
$0.81
52 Week High
$10.23
$3.19

Technical Indicators

Market Signals
Indicator
SNFCA
AKBA
Relative Strength Index (RSI) 44.85 45.96
Support Level $8.51 $0.85
Resistance Level $9.80 $0.98
Average True Range (ATR) 0.16 0.05
MACD 0.02 0.00
Stochastic Oscillator 45.45 29.27

Price Performance

Historical Comparison
SNFCA
AKBA

About SNFCA Security National Financial Corporation

Security National Financial Corp is a holding company providing insurance services. The company operates in three reportable business segments: Life insurance, Cemetery and Mortuary, and Mortgages. The life insurance segment sells and services selected lines of life insurance, annuity products, and accident and health insurance. The cemetery and mortuary segment engages in pre-need selling of funeral, cemetery, mortuary, and cremation services through its cemetery and mortuary locations. The mortgage segment originates and underwrites or otherwise purchases residential and commercial loans for new construction, existing homes, and other real estate projects. It derives the majority of revenue from Life Insurance segment.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Share on Social Networks: